Her scans were clean. Ultrasound and CT of her abdomen showed no swelling around the pancreas, no dead tissue, and nothing structurally wrong. Her lipase was 851.4 U/L and her amylase 346 U/L, both far above normal, and she had spent a month feeling progressively worse.
Writing in BMC Pulmonary Medicine, doctors from Taichung Armed Forces General Hospital in Taiwan described a 63-year-old woman with EGFR-mutated lung adenocarcinoma who developed acute pancreatitis one month after starting afatinib. She had come in with weakness, poor appetite, nausea, mouth ulcers, and tenderness around the navel.
